Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00358735 · ClinicalTrials.gov registry record · NA

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

A NA study of Bleeding and Pulmonary Embolism (PE), sponsored by Medical Compression Systems.

Completed
Registry status
NA
Development phase
411
Enrollment target
9
Study locations

NCT00358735 is a NA study of Bleeding and Pulmonary Embolism (PE) that has completed, run by Medical Compression Systems. The registered enrollment target is 411 participants, below the 1,467-participant average among 23 other Bleeding trials with a reported enrollment target (72% lower). The trial reports 9 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00358735, a NA study of Bleeding and Pulmonary Embolism (PE), has completed, sponsored by Medical Compression Systems.

COMPLETED
Registry status
NA
Development phase
411 participants
Enrollment target
9
Study locations

Study Summary

Evaluation of the safety and effectiveness of ActiveCare+ CECT device +/- baby dose aspirin (81 mg QD) for lowering the potential risk for bleeding and of DVT during and after THA surgery in comparison with LMWH.

Conditions Studied

Bleeding Pulmonary Embolism (PE) Deep Vein Thrombosis of Lower Limb

Interventions

  • DRUG Enoxaparin
  • DEVICE ActiveCare CECT device

Study Locations (9)

California

  • Scripps Clinic - La Jolla
  • Empire Orthopedic Center - Loma Linda
  • Cedars-Sinai Medical Center - Los Angeles

Indiana

  • The center for hip and knee surgery - Mooresville

Maryland

  • Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore - Baltimore

Minnesota

  • Mayo Clinic - Rochester

New York

  • Hospital for Special Surgery - New York

Ohio

  • Cleveland Clinic - Cleveland

Oregon

  • The Center Orthopedic & Neurosurgical Care &Research - Bend

Trial Details

FieldValue
Enrollment Target 411 participants
Start Date 2006-06
Est. Completion 2008-12
Phase NA

Sponsor

Medical Compression Systems

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00358735

The ClinicalTrials.gov registry entry for NCT00358735 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 411 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,467-participant average among 23 other Bleeding trials with a reported enrollment target (72% lower). The listed sponsor is Medical Compression Systems, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Bleeding appearing as the primary indexed condition, and to 2 interventions - of which Enoxaparin is the first listed.

NCT00358735 reports 9 study locations spanning 7 distinct geographic areas - top geographies include California, Indiana, Maryland.

Frequently Asked Questions

What is clinical trial NCT00358735 about?

NCT00358735 is a clinical study titled "Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)". Evaluation of the safety and effectiveness of ActiveCare+ CECT device +/- baby dose aspirin (81 mg QD) for lowering the potential risk for bleeding and of DVT during and after THA surgery in comparison with LMWH.

What is the current status of trial NCT00358735?

This trial is currently completed. It is a NA study. The enrollment target is 411 participants. The study started on 2006-06. Estimated completion is 2008-12.

What conditions does trial NCT00358735 study?

This clinical trial studies the following conditions: Bleeding, Pulmonary Embolism (PE), Deep Vein Thrombosis of Lower Limb.

What interventions are being tested in trial NCT00358735?

The interventions under investigation include: Enoxaparin (DRUG), ActiveCare CECT device (DEVICE).

Who is sponsoring clinical trial NCT00358735?

This trial is sponsored by Medical Compression Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00358735 being conducted?

This trial has 9 study locations across California, Indiana, Maryland, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bleeding

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Bleeding

All registered trials for this condition

Pulmonary Embolism (PE)

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.